STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
Jian Wang(Qilu Hospital of Shandong University), Jinming Gao(Northwest A&F University)
Cited by 5
Related Papers
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
|Nature Communications|2022|384
Prolonged activation of innate immune pathways by a polyvalent STING agonist
|Nature Biomedical Engineering|2021|298
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|225
A New Self-Healing Hydrogel Containing hucMSC-Derived Exosomes Promotes Bone Regeneration
|Frontiers in Bioengineering and Biotechnology|2020|147
mTOR Complex-2 Activates ENaC by Phosphorylating SGK1
|Journal of the American Society of Nephrology|2010|125